Searchable abstracts of presentations at key conferences in endocrinology

ea0011p499 | Endocrine tumours and neoplasia | ECE2006

Long-term somatostatin analog octreotide treatment in insulinoma patients

Vezzosi D , Bennet A , Courbon F , Caron P

The usefulness of long-term medical treatment with somatostatin analogs has not been evaluated in insulinomas. 22 patients with hypoglycaemia related to endogenous hyperinsulinism (62±21 years, M±S.D., 27–88 years) were not treated by surgery: aged patients (n=10), patients with malignant unresectable insulinomas (n=6; locally invasive, n=1; multimetastatic, n=5), multiple insulinomas (n=2), diffuse beta cell pat...